William C. Werkheiser
About
In The Last Decade
William C. Werkheiser
24 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 779
- Oncology 167
- Organic Chemistry 146
- Cancer Research 137
- Rheumatology 136
Countries citing papers authored by William C. Werkheiser
This map shows the geographic impact of William C. Werkheiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Werkheiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Werkheiser more than expected).
Fields of papers citing papers by William C. Werkheiser
This network shows the impact of papers produced by William C. Werkheiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Werkheiser. The network helps show where William C. Werkheiser may publish in the future.
Co-authorship network of co-authors of William C. Werkheiser
This figure shows the co-authorship network connecting the top 25 collaborators of William C. Werkheiser. A scholar is included among the top collaborators of William C. Werkheiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Werkheiser. William C. Werkheiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 101 | |
| 3 | 2 | |
| 4 | 23 | |
| 5 | 6 | |
| 6 | 32 | |
| 7 | 1 | |
| 8 | Conference on obstacles to the control of acute leukemia. Limitations on the therapeutic effectiveness of the folic acid antagonists. | 13 |
| 9 | 31 | |
| 10 | 70 | |
| 11 | 51 | |
| 12 | 43 | |
| 13 | 33 | |
| 14 | 324 | |
| 15 | 21 | |
| 16 | 12 | |
| 17 | 258 | |
| 18 | Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices. | 6 |
| 19 | Metabolic inhibitors and nucleotide turnover. II. Inhibition of uptake of C14-precursors in rat liver and hepatoma slices. | 6 |
| 20 | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.